Riken Vitamin Co., Ltd. (TYO:4526)

Riken Vitamin Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	17,905	20,070	22,298	23,384	19,155	17,302
Cash & Short-Term Investments	17,905	20,070	22,298	23,384	19,155	17,302
Cash Growth	-10.68%	-9.99%	-4.64%	22.08%	10.71%	-10.03%
Receivables	22,714	22,652	21,808	23,114	20,116	18,715
Inventory	23,150	22,061	19,610	18,581	17,735	15,076
Other Current Assets	1,519	1,444	1,983	1,442	1,120	1,697
Total Current Assets	65,288	66,227	65,699	66,521	58,126	52,790
Property, Plant & Equipment	28,153	27,829	25,525	23,382	23,637	25,428
Long-Term Investments	16,168	20,743	20,175	27,355	22,338	23,267
Other Intangible Assets	1,015	1,011	980	976	645	698
Long-Term Deferred Tax Assets	-	576	619	540	475	474
Other Long-Term Assets	6,716	1	1	2	2	2
Total Assets	117,340	116,387	112,999	118,776	105,223	102,660

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	8,225	7,822	7,899	9,900	8,257	7,696
Accrued Expenses	487	5,548	5,683	5,618	4,808	4,656
Short-Term Debt	2,235	1,941	3,373	11,938	3,306	3,674
Current Income Taxes Payable	284	1,877	1,656	1,352	1,163	226
Other Current Liabilities	7,389	2,246	2,518	2,309	1,390	1,969
Total Current Liabilities	18,620	19,434	21,129	31,117	18,924	18,221
Long-Term Debt	5,168	5,200	6,541	4,115	11,254	13,860
Pension & Post-Retirement Benefits	299	294	292	297	230	209
Long-Term Deferred Tax Liabilities	-	4,231	3,808	4,626	1,579	2,038
Other Long-Term Liabilities	8,858	3,849	2,030	1,979	1,866	1,794
Total Liabilities	32,945	33,008	33,800	42,134	33,853	36,122

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	2,537	2,537	2,537	2,537	2,537	2,537
Additional Paid-In Capital	2,466	2,466	2,466	2,466	2,466	3,072
Retained Earnings	68,666	68,413	64,774	65,290	58,729	65,426
Treasury Stock	-4,390	-3,927	-1,952	-7,954	-1,633	-13,785
Comprehensive Income & Other	15,073	13,850	11,337	14,273	9,245	9,269
Total Common Equity	84,352	83,339	79,162	76,612	71,344	66,519
Minority Interest	43	40	37	30	26	19
Shareholders' Equity	84,395	83,379	79,199	76,642	71,370	66,538
Total Liabilities & Equity	117,340	116,387	112,999	118,776	105,223	102,660

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	7,403	7,141	9,914	16,053	14,560	17,534
Net Cash (Debt)	10,502	12,929	12,384	7,331	4,595	-232
Net Cash Growth	5.94%	4.40%	68.93%	59.54%	-	-
Net Cash Per Share	361.73	437.72	409.01	224.76	140.07	-7.07
Filing Date Shares Outstanding	29.03	29.19	29.86	30.36	32.81	32.8
Total Common Shares Outstanding	29.03	29.19	29.87	30.36	32.81	32.8
Working Capital	46,668	46,793	44,570	35,404	39,202	34,569
Book Value Per Share	2905.42	2855.27	2649.91	2523.80	2174.34	2027.81
Tangible Book Value	83,337	82,328	78,182	75,636	70,699	65,821
Tangible Book Value Per Share	2870.45	2820.63	2617.10	2491.65	2154.68	2006.53

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error